1 / 29

CHAPTER 9 Respiratory-Related Microbiological Diseases

CHAPTER 9 Respiratory-Related Microbiological Diseases. 9-2. Introduction. Respiratory system Serves as host for infectious diseases, although contains many layers of defense Warm, moist atmosphere facilitating microbacterial growth Site for constant inhalation of environmental particles.

peakj
Download Presentation

CHAPTER 9 Respiratory-Related Microbiological Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CHAPTER 9Respiratory-Related MicrobiologicalDiseases 9-2

  2. Introduction Respiratory system Serves as host for infectious diseases, although contains many layers of defense Warm, moist atmosphere facilitating microbacterial growth Site for constant inhalation of environmental particles 9-3

  3. Upper Respiratory Infections • Includes • Sinusitis • Pharyngitis • Epiglottitis • Croup 9-4

  4. Description Inflammation of hollow sinuses in nasal cavity Viral or bacterial Signs/Symptoms (S/S) (not limited to): nasal stuffiness and discharge; pain/pressure in face; if bacterial, yellow or green nasal discharge Diagnostic Observe for ten days to determine if self-limiting or if treatment required (Continues) Sinusitis 9-5

  5. Treatment Oral decongestants Topical decongestants Nasal steroids Analgesics Antibiotics Sinusitis 9-6

  6. Description Inflammation of pharynx and surrounding lymphatic tissue Viral or bacterial S/S (not limited to): sore throat; dysphagia; fever; white, mucosal patches Treatment: usually self-limiting; if bacterial, antibiotics Severe complications, if untreated Pharyngitis 9-7

  7. Description Acute airway obstruction (airway emergency) Prevalent in children 2–6 years of age Abrupt onset (usually due to haemophilis influenzae Type B) Symptoms (4 Ds): distress (respiratory), drooling, dysphasia, dysphonia Treatment Maintain airway Antibiotic therapy Epiglottitis 9-8

  8. Description Infection of laryngeal area, prevalent in children younger than 3 years of age Usually viral S/S: barking cough, stridor, may be afebrile Treatment: air humidification, administration of oxygen, nebulized epinephrine or corticosteroids Croup 9-9

  9. Lower Respiratory Infections • Includes • Acute bronchitis • Acute bronchiolitis • Pneumonia • Tuberculosis 9-10

  10. Description Affects bronchi; common in winter months Usually viral and may be self-limiting S/S: may progress from nonspecific symptoms (e.g., headache, sore throat) to thick bronchial secretions with productive cough; bilateral rhonchi and coarse crackles Treatment: symptomatic treatment, antibiotics (if bronchitis due to pertussis) Acute Bronchitis 9-11

  11. Bronchiolitis Description Affects bronchioles, especially in infants 2–10 months of age; often in winter–spring months S/S (not limited to): restlessness, mild fever, noisy upper airway breathing, tachypnea Most common cause: RSV Treatment: antivirals, aerosolized drug using special nebulizer equipment (hood or mist tent) 9-12

  12. Pneumonia • Many types • Community-acquired pneumonia • Atypical pneumonia • Viral pneumonia • Tracheobronchitis • HCAP, VAP, HAP • Aspiration pneumonia • Pneumocystis jiroveci (Continues) 9-13

  13. Pneumonia Description Causes: virus, bacteria, fungus, drugs or chemicals S/S (not limited to): leukocytosis, fever, rhonchi, dullness of percussion at site Diagnostic: chest x-ray and cultures of sputum and blood Assess respiratory function to determine need for hospitalization 9-14

  14. CAP Description of infection is determined by prevalent pathogens, not geographical location Usual cause: Streptococcus pneumoniae Treatment Determined by such guidelines as local resistance patterns, clinical condition, chest x-ray results Recommended treatments are frequently updated Community-Acquired Pneumonia 9-15

  15. Atypical Pneumonia • Description • Cause: organisms not detectable by gram stain, nor growth on standard cultural media • Organisms do not respond to antibiotics used to treat pneumonia • Often due to Mycoplasma pneumoniae, Legionella, Chlamydophila pneumoniae • Treatment • Empiric therapy 9-16

  16. Viral Pneumonia • Description • Determined by molecular diagnostic methods, such as polymerase chain reaction (PCR) test • Must rule out bacterial cause • Bacteria and virus can coinfect • If bacterial, treat with antibiotics 9-17

  17. Tracheobronchitis • Pneumonia-like infection caused by mechanical ventilation • S/S: fever, new/increased sputum production • Diagnostic: sputum sample from endotracheal tube for gram stain and culture • Treatment • Antibiotics (determined by local antibiotic susceptibility patterns) 9-18

  18. HCAP, VAP, HAP • Health care–associated (HCAP), ventilator- associated (VAP), hospital-acquired (HAP) • Pneumonia related to exposure to/frequent contact with health care settings • Preventive measures: decrease aspiration by patients; prevent cross-contamination; disinfection/sterilization of respiratory devices; vaccines against certain infections; education of hospital staff and patients 9-19

  19. Aspiration Pneumonia • Two types • Chemical • Exposure to stomach acid • Treatment: symptomatic therapy allowing lungs to heal • Bacterial • Due to aspiration of oropharyngeal organisms, or aerosol inhalation • Treatment: empiric antibiotic therapy 9-20

  20. Pneumocystis jiroveci (Carinii) • Description • Due to defects in cell-mediated immunity (e.g., complications of HIV; organ or bone marrow transplantation; medications) • S/S (not limited to): asymptomatic (or) fever, cough, tachypnea, dyspnea • Diagnostic: ABGs • Treatment: specific IV or parenteral medications 9-21

  21. Tuberculosis • Airborne, chronic disease due to Mycobacterium tuberculosis • Latent: inhaled droplet is encapsulated • Active: inhaled droplet (bacilli) escapes • S/S: asymptomatic (or) weight loss, fever, night sweats, bloody sputum • Diagnostic: Mantoux or PPD, testing of sputum specimen, chest x-ray (Continues) 9-22

  22. Tuberculosis • Treatment • If latent • Preventive treatment (isoniazid 6–12 months) • If active • Medication regimen 6–24 months • Directly observed treatment (DOT) may be required due to noncompliance 9-23

  23. Bioterrorism • Pulmonary irritants • Chlorine, phosgene • Biochemical reactions of irritants cause laryngospasm and pulmonary edema • Anthrax • Transmission: skin contact, inhalation • If inhaled, spores are transported to lymph system, germinate and produce toxins • Treatment: antibiotics (Continues) 9-24

  24. Bioterrorism • Plague • Potential bioweapon, contagious • Transmission: close contact, aerosol • Treatment • If systemic: parenteral antibiotic therapy • Prophylaxis (post-exposure): oral antibiotics • Vaccine no longer available; discontinued in 1999 9-25

  25. Avian Influenza (H5N1) • Carried in intestines of wild birds; transmitted to domestic birds, including poultry (cause of human exposure) • May be transmitted through touching contaminated surfaces • S/S noted after a 2- to 5-day incubation period include (not limited to) fever, cough, rhinorrhea, diarrhea, abdominal pain (Continues) 9-26

  26. Avian Influenza (H5N1) • Symptoms may progress to acute respiratory distress syndrome • Treatment • Prophylaxis and supportive treatment • Antiviral medications • Includes treatment of anyone living with infected patient 9-27

  27. Summary • Clinical presentation, diagnosis, treatment of respiratory system infections • Upper respiratory infections • Lower respiratory infections • Bioterrorism • Avian influenza (Continues) 9-28

  28. Summary • Many upper respiratory tract infections due to viruses • Treating viral infections with antibiotics promotes bacterial resistance • Refer to text/tables for in-depth information 9-29

More Related